Pre-Open Stock Movers 10/28: (IFRX) (MIME) (OSTK) Higher; (TWLO) (NTGR) (FLEX) Lower (more...)

Pre-Open Stock Movers:

Inflarx NV (NASDAQ: IFRX) 55% HIGHER; Raymond James upgraded from Outperform to Strong Buy with a price target of $14.00.

Twilio (NYSE: TWLO) 16.8% LOWER; reported Q3 EPS of $0.01, $0.15 better than the analyst estimate of ($0.14). Revenue for the quarter came in at $740.2 million versus the consensus estimate of $680.49 million. Twilio sees Q4 2021 EPS of ($0.26)-($0.23), versus the consensus of ($0.07). Twilio sees Q4 2021 revenue of $760-770 million, versus the consensus of $744.7 million.

Mimecast Limited (NASDAQ: MIME) 7.3% HIGHER; is exploring a possible sale, the Wall Street Journal reported.

Overstock.com (NASDAQ: OSTK) 7.3% HIGHER; reported Q3 EPS of $0.63, $0.16 better than the analyst estimate of $0.47. Revenue for the quarter came in at $689 million versus the consensus estimate of $682.83 million.

Netgear, Inc. (NASDAQ: NTGR) 7.5% LOWER; reported Q3 EPS of $0.50, $0.09 better than the analyst estimate of $0.41. Revenue for the quarter came in at $290.2 million versus the consensus estimate of $294.96 million. Netgear, Inc. sees Q4 2021 revenue of $250-265 million, versus the consensus of $328 million.

Ford Motor (NYSE: F) 7.3% HIGHER; reported Q3 EPS of $0.51, $0.24 better than the analyst estimate of $0.27. Revenue for the quarter came in at $35.7 billion versus the consensus estimate of $33.11 billion. Reinstates dividend.

Align Technology (NASDAQ: ALGN) 7.2% HIGHER; reported Q3 EPS of $2.87, $0.27 better than the analyst estimate of $2.60. Revenue for the quarter came in at $1.02 billion versus the consensus estimate of $977.8 million. Align Technology sees FY2021 revenue of $3.9-3.95 billion, versus the consensus of $3.94 billion.

Flex Ltd. (NASDAQ: FLEX) 6% LOWER; reported Q2 EPS of $0.48, $0.13 better than the analyst estimate of $0.35. Revenue for the quarter came in at $6.2 billion versus the consensus estimate of $5.49 billion. Flex Ltd. sees Q3 2022 EPS of $0.38-$0.44, versus the consensus of $0.42. Flex Ltd. sees Q3 2022 revenue of $6.1-6.5 billion, versus the consensus of $5.91 billion. Flex Ltd. sees FY2022 EPS of $1.70-$1.85, versus the consensus of $1.54. Flex Ltd. sees FY2022 revenue of $24.8-25.8 billion, versus the consensus of $22.41 billion.

Impinj (NASDAQ: PI) 5.4% HIGHER; reported Q3 EPS of ($0.04), $0.06 better than the analyst estimate of ($0.10). Revenue for the quarter came in at $45.2 million versus the consensus estimate of $44.15 million. Impinj sees Q4 2021 EPS of ($0.04)-$0.02, versus the consensus of ($0.14). Impinj sees Q4 2021 revenue of $46-48 million, versus the consensus of $42.3 million.

Comcast (NASDAQ: CMCSA) 5.2% HIGHER; reported Q3 EPS of $0.87, $0.12 better than the analyst estimate of $0.75. Revenue for the quarter came in at $30.3 billion versus the consensus estimate of $29.77 billion.

Teladoc (NYSE: TDOC) 5% LOWER; reported Q3 EPS of ($0.53), $0.12 better than the analyst estimate of ($0.65). Revenue for the quarter came in at $522 million versus the consensus estimate of $516.6 million. Teladoc sees Q4 2021 EPS of ($0.73)-($0.53), versus the consensus of ($0.69). Teladoc sees Q4 2021 revenue of $536-546 million, versus the consensus of $539.74 million. Teladoc sees FY2021 EPS of ($3.40)-($3.20), versus the consensus of ($3.37). Teladoc sees FY2021 revenue of $2.015-2.025 billion, versus the consensus of $2.01 billion.

ServiceNow (NYSE: NOW) 4.8% LOWER; reported Q3 EPS of $1.55, $0.17 better than the analyst estimate of $1.38. Revenue for the quarter came in at $1.51 billion versus the consensus estimate of $1.47 billion.

Teradyne (NASDAQ: TER) 4.3% HIGHER; reported Q3 EPS of $1.59, $0.16 better than the analyst estimate of $1.43. Revenue for the quarter came in at $951 million versus the consensus estimate of $932.88 million. Teradyne sees Q4 2021 EPS of $1.14-$1.40, versus the consensus of $1.18. Teradyne sees Q4 2021 revenue of $820-900 million, versus the consensus of $851 million.

Edwards Lifesciences (NYSE: EW) 4% LOWER; reported Q3 EPS of $0.54, in-line with the analyst estimate of $0.54. Revenue for the quarter came in at $1.3 billion versus the consensus estimate of $1.33 billion. Edwards Lifesciences sees Q4 2021 EPS of $0.53-$0.59, versus the consensus of $0.56. Edwards Lifesciences sees Q4 2021 revenue of $1.3-1.38 billion, versus the consensus of $1.41 billion.

Tesla (NASDAQ: TSLA) 2.8% HIGHER; Piper Sandler analyst Alexander Potter reiterated an Overweight rating and raised the price target to $1,300.00 per share from the prior $1,200.00.

Merck (NYSE: MRK) 2% HIGHER; reported Q3 EPS of $1.75, $0.20 better than the analyst estimate of $1.55. Revenue for the quarter came in at $13.2 billion versus the consensus estimate of $12.33 billion. Merck sees FY2021 EPS of $5.65-$5.70, versus the consensus of $5.77. Merck sees FY2021 revenue of $47.4-47.9 billion, versus the consensus of $48.16 billion.

You May Also Be Interested In

• Midday movers: Meta, IBM, Caterpillar fall; Chipotle rises
• After-hours movers: Tesla, Texas Instruments, Seagate, Visa and more
• IT services stocks fall following Infosys' numbers